| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 122.59B | 115.10B | 119.76B | 115.22B | 114.88B | 117.11B |
| Gross Profit | 26.90B | 24.87B | 25.25B | 21.94B | 24.45B | 32.23B |
| EBITDA | 18.72B | 17.32B | 17.00B | 14.46B | 16.01B | 24.19B |
| Net Income | 8.99B | 7.80B | 8.36B | 6.83B | 8.07B | 13.69B |
Balance Sheet | ||||||
| Total Assets | 125.88B | 130.10B | 131.46B | 124.50B | 131.25B | 122.07B |
| Cash, Cash Equivalents and Short-Term Investments | 5.40B | 6.72B | 7.16B | 9.68B | 10.93B | 16.93B |
| Total Debt | 20.63B | 18.29B | 19.20B | 16.39B | 22.52B | 20.16B |
| Total Liabilities | 55.23B | 57.47B | 59.54B | 58.01B | 69.18B | 64.57B |
| Stockholders Equity | 67.80B | 69.68B | 69.09B | 63.74B | 59.35B | 54.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.13B | -1.45B | 7.94B | -5.36B | 13.00B |
| Operating Cash Flow | 0.00 | 13.78B | 6.98B | 13.20B | 5.13B | 17.40B |
| Investing Cash Flow | 0.00 | -4.63B | -8.90B | -4.94B | -10.08B | -4.39B |
| Financing Cash Flow | 0.00 | -9.57B | -645.00M | -9.50B | -1.08B | -5.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥44.91B | 8.53 | ― | 3.53% | -3.45% | 30.52% | |
73 Outperform | ¥203.29B | 16.43 | 4.41% | 3.80% | -1.50% | -32.46% | |
68 Neutral | ¥865.05B | 25.35 | 4.79% | 4.21% | -1.21% | -27.21% | |
67 Neutral | ¥115.01B | 14.28 | ― | 3.88% | 2.61% | 30.29% | |
65 Neutral | ¥92.55B | 35.93 | ― | 0.67% | 10.18% | -14.36% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥575.10B | 78.15 | 1.08% | 3.37% | -1.94% | -84.08% |
KH Neochem reported a slight decline in performance for the fiscal year ended December 31, 2025, with net sales down 3.9% year on year to ¥115.1 billion and operating income falling 7.8% to ¥11.2 billion, while net income attributable to owners of the parent decreased 6.7% to ¥7.8 billion. Despite softer profits, the company maintained a solid financial position, with total assets of ¥130.1 billion, an equity ratio of 53.6%, and strong operating cash flow of ¥13.8 billion that comfortably funded investments and higher shareholder returns. The annual dividend was raised from ¥90 to ¥105 per share for 2025, lifting the payout ratio to 48.1%, and management plans a further increase to ¥110 per share in 2026, signaling continued commitment to shareholder returns. For the 2026 fiscal year, KH Neochem forecasts marginally lower full-year sales of ¥114.0 billion but expects operating income to rise 20.0% and net income to grow 11.5% to ¥8.7 billion, implying improved profitability and a more efficient earnings structure even in a flat or slightly weaker revenue environment.
The most recent analyst rating on (JP:4189) stock is a Hold with a Yen2798.00 price target. To see the full list of analyst forecasts on KH Neochem Co.,Ltd. stock, see the JP:4189 Stock Forecast page.
KH Neochem has cut its full-year consolidated forecast for the fiscal year ending December 31, 2025, trimming expected net sales from 127.4 billion yen to 115.0 billion yen and lowering projected operating income, ordinary income and net income by roughly 20–23% versus its previous outlook, bringing all major profit metrics below FY2024 levels. The downgrade reflects weak domestic demand and intensified competition from low-cost imports in basic chemicals, as well as a sharper-than-expected downturn in performance materials following a post-regulation demand recoil in the U.S. and a temporary slowdown in the air conditioner market linked to reduced impact from China’s appliance replacement subsidies, which has weighed on sales of refrigeration lubricant raw materials; nevertheless, the company is maintaining its dividend forecast for FY2025 and currently anticipates a recovery in FY2026 operating profit to around 13 billion yen, suggesting expectations of gradual operational improvement despite near-term headwinds.
The most recent analyst rating on (JP:4189) stock is a Hold with a Yen2772.00 price target. To see the full list of analyst forecasts on KH Neochem Co.,Ltd. stock, see the JP:4189 Stock Forecast page.